ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced the composition of its Board of Directors, which includes three Executive Directors, one Non-executive Director, and three Independent Non-executive Directors. The company also detailed the membership of its three Board committees: Audit, Remuneration, and Nomination, each led by different chairmen and composed of various members of the Board.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.